Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. [electronic resource]

By:

Foa, Edna B

Contributor(s):

Simpson, Helen Blair
Rosenfield, David
Liebowitz, Michael R
Cahill, Shawn P
Huppert, Jonathan D
Bender, James
McLean, Carmen P
Maher, Michael J
Campeas, Raphael
Hahn, Chang-Gyu
Imms, Patricia
Pinto, Anthony
Powers, Mark B
Rodriguez, Carolyn I
Van Meter, Page E
Vermes, Donna
Williams, Monnica T

Producer: 20150629Description: 440-6 p. digitalISSN:

1555-2101

Subject(s):

Adolescent
Adult
Aged
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Implosive Therapy
Male
Middle Aged
Obsessive-Compulsive Disorder -- diagnosis
Risperidone -- adverse effects
Selective Serotonin Reuptake Inhibitors -- adverse effects
United States
Young Adult

Online resources:

Available from publisher's website

In: The Journal of clinical psychiatry vol. 76

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

There are no comments on this title.

Browse results Close

Back to results

1 [From clinical medicine to experimentation: cerebral vascular accidents, a new field for the use of a coronarodilator, carbochromene].
by Giovannoni, L
2 Highly fluorescent protein labeling using dendritic peptide derivatives.
by Giovannoni, L
3 Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening.
by Giovannoni, L
4 Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.
by Viti, F
5 The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity.
by Hemmerle, T
6 Open visiting policies in Intensive Care Units may not affect consent to organ donation.
by Bambi, S
7 Prevalence of genetic risk factors for coronary artery disease in Corsica island (France).
by Falchi, A
8 A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage.
by Demartis, S
9 Cholesteryl ester transfer protein gene polymorphisms are associated with coronary artery disease in Corsican population (France).
by Falchi, A
10 Experimental study of argon laser-induced microthrombosis during PGI2 infusion.
by Boncinelli, S
11 A functional circadian clock is required for proper insulin secretion by human pancreatic islet cells.
by Saini, C
12 Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.
by Spitaleri, G
13 Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis.
by Dietrich, T
14 Autonomous and self-sustained circadian oscillators displayed in human islet cells.
by Pulimeno, P
15 A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate.
by Galeazzi, M

Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.

APA

Foa E. B., Simpson H. B., Rosenfield D., Liebowitz M. R., Cahill S. P., Huppert J. D., Bender J., McLean C. P., Maher M. J., Campeas R., Hahn C., Imms P., Pinto A., Powers M. B., Rodriguez C. I., Van Meter P. E., Vermes D. & Williams M. T. (20150629). Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. : The Journal of clinical psychiatry.

Chicago

Foa Edna B, Simpson Helen Blair, Rosenfield David, Liebowitz Michael R, Cahill Shawn P, Huppert Jonathan D, Bender James, McLean Carmen P, Maher Michael J, Campeas Raphael, Hahn Chang-Gyu, Imms Patricia, Pinto Anthony, Powers Mark B, Rodriguez Carolyn I, Van Meter Page E, Vermes Donna and Williams Monnica T. 20150629. Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. : The Journal of clinical psychiatry.

Harvard

Foa E. B., Simpson H. B., Rosenfield D., Liebowitz M. R., Cahill S. P., Huppert J. D., Bender J., McLean C. P., Maher M. J., Campeas R., Hahn C., Imms P., Pinto A., Powers M. B., Rodriguez C. I., Van Meter P. E., Vermes D. and Williams M. T. (20150629). Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. : The Journal of clinical psychiatry.

MLA

Foa Edna B, Simpson Helen Blair, Rosenfield David, Liebowitz Michael R, Cahill Shawn P, Huppert Jonathan D, Bender James, McLean Carmen P, Maher Michael J, Campeas Raphael, Hahn Chang-Gyu, Imms Patricia, Pinto Anthony, Powers Mark B, Rodriguez Carolyn I, Van Meter Page E, Vermes Donna and Williams Monnica T. Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. : The Journal of clinical psychiatry. 20150629.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC